Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brach, B.
Right arrow Articles by Liprie, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brach, B.
Right arrow Articles by Liprie, S. F.
(Chest. 1994;106:268-274.)
© 1994 American College of Chest Physicians

Percutaneous Computed Tomography-guided Fine Needle Brachytherapy of Pulmonary Malignancies

Bernard Brach M.D., F.C.C.P.1; Carl Buhler M.S.1; Michael H. Hayman M.D.1; Lee Roy Joyner Jr. M.D., F.C.C.P.1; and Samuel F. Liprie P.D., R.Ph.1

1 From the East Jefferson General Hospital, Center For Living With Cancer, Metairie, La; and St. Francis Medical Center, Monroe, La.

Small caliber needle aspiration of lung lesions has been successfully and safely used for diagnostic purposes. We report our initial experience using computed tomography-guided fine needle percutaneous implantation for direct intralesional high-dose rate brachytherapy for malignant pulmonary lesions. Twenty patients with primary lung cancer or metastatic cancer which involved the lung or chest wall were treated with a highdose rate remote afterloader. Eighteen of the 20 patients also received external beam radiation in conjunction with intralesional radiation therapy. Fourteen patients had primary lung cancer. A complete response was obtained in 5 of the 14 patients. Ten of the 14 patients with primary non-small-cell carcinoma of the lung showed a significant response to treatment (greater than 50 percent reduction in tumor measurement). Six patients with metastatic lesions also were treated. Five of the six showed a significant tumor response measured as either 50 percent reduction in tumor measurement or complete pain relief. The only significant complication was pneumothorax (6 of the 20), which did not prevent completion of any treatment plan.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
B. Ghaye and R.F. Dondelinger
Imaging guided thoracic interventions
Eur. Respir. J., March 1, 2001; 17(3): 507 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
T. Kobayashi, M. Kaneko, M. Sumi, K. Kubota, and H. Kondo
CT-assisted Transbronchial Brachytherapy for Small Peripheral Lung Cancer
Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 109 - 112.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.